235 related articles for article (PubMed ID: 34831151)
21. Lowered paraoxonase 1 (PON1) activity is associated with increased cytokine levels in drug naïve first episode psychosis.
Brinholi FF; Noto C; Maes M; Bonifácio KL; Brietzke E; Ota VK; Gadelha A; Cordeiro Q; Belangero SI; Bressan RA; Vargas HO; Higachi L; de Farias CC; Moreira EG; Barbosa DS
Schizophr Res; 2015 Aug; 166(1-3):225-30. PubMed ID: 26123170
[TBL] [Abstract][Full Text] [Related]
22. Innate Immune Cells and C-Reactive Protein in Acute First-Episode Psychosis and Schizophrenia: Relationship to Psychopathology and Treatment.
Steiner J; Frodl T; Schiltz K; Dobrowolny H; Jacobs R; Fernandes BS; Guest PC; Meyer-Lotz G; Borucki K; Bahn S; Bogerts B; Falkai P; Bernstein HG
Schizophr Bull; 2020 Feb; 46(2):363-373. PubMed ID: 31504969
[TBL] [Abstract][Full Text] [Related]
23. [Stress and psychotic transition: A literature review].
Chaumette B; Kebir O; Mam Lam Fook C; Bourgin J; Godsil BP; Gaillard R; Jay TM; Krebs MO
Encephale; 2016 Aug; 42(4):367-73. PubMed ID: 27161263
[TBL] [Abstract][Full Text] [Related]
24. Immune and metabolic alterations in first episode psychosis (FEP) patients.
Bocchio-Chiavetto L; Zanardini R; Tosato S; Ventriglia M; Ferrari C; Bonetto C; Lasalvia A; Giubilini F; Fioritti A; Pileggi F; Pratelli M; Pavanati M; Favaro A; De Girolamo G; Frisoni GB; Ruggeri M; Gennarelli M;
Brain Behav Immun; 2018 May; 70():315-324. PubMed ID: 29548996
[TBL] [Abstract][Full Text] [Related]
25. Association of Hippocampal Atrophy With Duration of Untreated Psychosis and Molecular Biomarkers During Initial Antipsychotic Treatment of First-Episode Psychosis.
Goff DC; Zeng B; Ardekani BA; Diminich ED; Tang Y; Fan X; Galatzer-Levy I; Li C; Troxel AB; Wang J
JAMA Psychiatry; 2018 Apr; 75(4):370-378. PubMed ID: 29466532
[TBL] [Abstract][Full Text] [Related]
26. Theory of mind impairments in first-episode psychosis, individuals at ultra-high risk for psychosis and in first-degree relatives of schizophrenia: systematic review and meta-analysis.
Bora E; Pantelis C
Schizophr Res; 2013 Mar; 144(1-3):31-6. PubMed ID: 23347949
[TBL] [Abstract][Full Text] [Related]
27. Deregulation of complement components C4A and CSMD1 peripheral expression in first-episode psychosis and links to cognitive ability.
Hatzimanolis A; Foteli S; Stefanatou P; Ntigrintaki AA; Ralli I; Kollias K; Nikolaou C; Gazouli M; Stefanis NC
Eur Arch Psychiatry Clin Neurosci; 2022 Oct; 272(7):1219-1228. PubMed ID: 35532796
[TBL] [Abstract][Full Text] [Related]
28. Complement system biomarkers in first episode psychosis.
Kopczynska M; Zelek W; Touchard S; Gaughran F; Di Forti M; Mondelli V; Murray R; O'Donovan MC; Morgan BP
Schizophr Res; 2019 Feb; 204():16-22. PubMed ID: 29279246
[TBL] [Abstract][Full Text] [Related]
29. Allostatic load is associated with psychotic symptoms and decreases with antipsychotic treatment in patients with schizophrenia and first-episode psychosis.
Berger M; Juster RP; Westphal S; Amminger GP; Bogerts B; Schiltz K; Bahn S; Steiner J; Sarnyai Z
Psychoneuroendocrinology; 2018 Apr; 90():35-42. PubMed ID: 29427955
[TBL] [Abstract][Full Text] [Related]
30. Immunological protein profiling of first-episode psychosis patients identifies CSF and blood biomarkers correlating with disease severity.
Eren F; Schwieler L; Orhan F; Malmqvist A; Piehl F; Cervenka S; Sellgren CM; Fatouros-Bergman H; Engberg G; Erhardt S
Brain Behav Immun; 2023 Jul; 111():376-385. PubMed ID: 37146654
[TBL] [Abstract][Full Text] [Related]
31. Prevalence of psychotic and non-psychotic disorders in relatives of patients with a first episode psychosis.
Faridi K; Pawliuk N; King S; Joober R; Malla AK
Schizophr Res; 2009 Oct; 114(1-3):57-63. PubMed ID: 19666214
[TBL] [Abstract][Full Text] [Related]
32. Angiogenic and immune signatures in plasma of young relatives at familial high-risk for psychosis and first-episode patients: A preliminary study.
Lizano PL; Keshavan MS; Tandon N; Mathew IT; Mothi SS; Montrose DM; Yao JK
Schizophr Res; 2016 Jan; 170(1):115-22. PubMed ID: 26692348
[TBL] [Abstract][Full Text] [Related]
33. Investigation of peripheral complement factors across stages of psychosis.
Laskaris L; Zalesky A; Weickert CS; Di Biase MA; Chana G; Baune BT; Bousman C; Nelson B; McGorry P; Everall I; Pantelis C; Cropley V
Schizophr Res; 2019 Feb; 204():30-37. PubMed ID: 30527272
[TBL] [Abstract][Full Text] [Related]
34. Association between catechol-O-methyltransferase genetic variation and functional connectivity in patients with first-episode schizophrenia.
Wang H; Zhang B; Zeng B; Tang Y; Zhang T; Zhao S; Li C; Wang J; Goff DC
Schizophr Res; 2018 Sep; 199():214-220. PubMed ID: 29730044
[TBL] [Abstract][Full Text] [Related]
35. Trajectory of neurological examination abnormalities in antipsychotic-naïve first-episode psychosis population: a 1 year follow-up study.
Lizano P; Dhaliwal K; Lutz O; Mothi SS; Miewald J; Montrose D; Keshavan M
Psychol Med; 2020 Sep; 50(12):2057-2065. PubMed ID: 31451118
[TBL] [Abstract][Full Text] [Related]
36. Microglial Activation and Psychotic Disorders: Evidence from Pre-clinical and Clinical Studies.
Barichello T; Simoes LR; Quevedo J; Zhang XY
Curr Top Behav Neurosci; 2020; 44():161-205. PubMed ID: 30828767
[TBL] [Abstract][Full Text] [Related]
37. Visual P3 abnormalities in patients with first-episode schizophrenia, unaffected siblings of schizophrenia patients and individuals at ultra-high risk for psychosis.
Devrim-Üçok M; Keskin-Ergen HY; Üçok A
Prog Neuropsychopharmacol Biol Psychiatry; 2023 Mar; 122():110678. PubMed ID: 36427549
[TBL] [Abstract][Full Text] [Related]
38. Cognitive deficits in clinical and familial high risk groups for psychosis are common as in first episode schizophrenia.
Üçok A; Direk N; Koyuncu A; Keskin-Ergen Y; Yüksel Ç; Güler J; Karadayı G; Akturan E; Devrim-Üçok M
Schizophr Res; 2013 Dec; 151(1-3):265-9. PubMed ID: 24262680
[TBL] [Abstract][Full Text] [Related]
39. Gene expression alterations related to mania and psychosis in peripheral blood of patients with a first episode of psychosis.
Gouvea ES; Ota VK; Noto C; Santoro ML; Spindola LM; Moretti PN; Carvalho CM; Xavier G; Rios AC; Sato JR; Hayashi MA; Brietzke E; Gadelha A; Bressan RA; Cordeiro Q; Belangero SI
Transl Psychiatry; 2016 Oct; 6(10):e908. PubMed ID: 27701407
[TBL] [Abstract][Full Text] [Related]
40. MMN/P3a deficits in first episode psychosis: comparing schizophrenia-spectrum and affective-spectrum subgroups.
Kaur M; Battisti RA; Ward PB; Ahmed A; Hickie IB; Hermens DF
Schizophr Res; 2011 Aug; 130(1-3):203-9. PubMed ID: 21550211
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
